Knott David M Jr »

Alkermes shares owned by Knott David M Jr

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-09-30 $579k 19k 30.00
2025-06-30 $1.4M 49k 28.61
2023-09-30 $630k 23k 28.01
2023-06-30 $2.1M 67k 31.30

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Janus Henderson AAA CLO ETF Common (JAAA)
Darling Ingredients Common Call Option (DAR)
Xeris Biopharma Holdings Common (XERS)
Syndax Pharmaceutical Common (SNDX)
JPMorgan Chase & Co. Common (JPM)
Travere Therapeutics Common (TVTX)
Avadel Pharmaceuticals Common (AVDL)
Protagonist Therapeutics Common (PTGX)
Bridgebio Pharma Common (BBIO)
DocGo Common (DCGO)
Verona Pharma Common (VRNA)
LENZ Therapeutics Common (LENZ)

View all positions for Knott David M Jr

Top funds holding Alkermes

BlackRock
Vanguard Group
State Street Corporation
Baker Bros. Advisors
Renaissance Technologies
American Century Companies
Geode Capital Management
Jpmorgan Chase & Co
Dimensional Fund Advisors
Commodore Capital
PRIMECAP Management Company
Holocene Advisors
venBio Select Advisor
Nuveen
Charles Schwab Investment Management

View all funds holding Alkermes